Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Organogenesis Inc.
The UK biotech has struck up an unusual deal with its new investor that lets it retain control over its assets, as it raises $54m in a series A.
Market Brief: Tissue-Engineered Wound Care Market Expected To Reach $1.9Bn By 2024 Amid Rising Chronic Disease
The skin replacement market is led by three key players who have all been impacted by COVID-19, but the sector may see a quicker rebound than others as treatments cannot be deferred for a long time.
Takeda’s collaboration with the private UK biotech includes NASH and other liver disorders. Reliance will take on Amazon in the India pharmacy space with acquisition of Netmeds.
Surprise provision directs favorable Medicare Part B reimbursement for a handful of therapeutics beginning later this year.
- Other Names / Subsidiaries
- Avista Capital Partners
- Avista Healthcare Public Acquisition Corporation
- GCM Holding Corporation
- Inform Diagnostics, Inc.
- Kramer Laboratories
- Miraca Life Sciences, Inc.
- NuTech Medical
- NuTech Spine.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.